In mouse models of fibromyalgia and post-operative pain, all four compounds produced substantial pain-relieving effects
In the open letter, Lilly emphasized that its GLP-1 products are indicated for the treatment of serious diseases and are not approved forand should not be used forcosmetic weight loss. The pharma also said that it does not endorse the use of Mounjaro and Zepbound outside of its approved indications, and that patients should only use these medications following the prescription of a licensed healthcare professional
PMID: 30312372
This compound is commonly used in nutraceutical manufacturing, nootropic blends, and laboratory research due to its role in glutathione metabolism and brain-support formulations
Novo Nordisk is awaiting an FDA decision for their fixed-dose combination of the amylin receptor agonist, cagrilintide, and the GLP-1, semaglutide
At Cymbiotika, we emphasize the importance of transparency in our supplement formulations, ensuring that our community is informed about the ingredients and potential effects of our products